PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures - PubMed (original) (raw)
. 2003 Feb 17;456(4):375-83.
doi: 10.1002/cne.10536.
Affiliations
- PMID: 12532409
- DOI: 10.1002/cne.10536
PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures
Robert P Brendza et al. J Comp Neurol. 2003.
Abstract
Neuritic plaques are one of the stereotypical hallmarks of Alzheimer's disease (AD) pathology. These structures are composed of extracellular accumulations of fibrillar forms of the amyloid-beta peptide (Abeta), a variety of other plaque-associated proteins, activated glial cells, and degenerating nerve processes. To study the neuritic toxicity of different structural forms of Abeta in the context of regional connectivity and the entire cell, we crossed PDAPP transgenic (Tg) mice, a model with AD-like pathology, to Tg mice that stably express yellow fluorescent protein (YFP) in a subset of neurons in the brain. In PDAPP; YFP double Tg mice, markedly enlarged YFP-labeled axonal and dendritic varicosities were associated with fibrillar Abeta deposits. These varicosities were absent in areas where there were nonfibrillar Abeta deposits. Interestingly, YFP-labeled varicosities revealed changes that corresponded with changes seen with electron microscopy and the de Olmos silver staining technique. Other silver staining methods and immunohistochemical localization of phosphorylated neurofilaments or phosphorylated tau were unable to detect the majority of these dystrophic neurites. Some but not all synaptic vesicle markers accumulated abnormally in YFP-labeled varicosities associated with neuritic plaques. In addition to the characterization of the effects of Abeta on axonal and dendritic structure, YFP-labeled neurons in Tg mice should prove to be a valuable tool to interpret the localization patterns of other markers and for future studies examining the dynamics of axons and dendrites in a variety of disease conditions in living tissue both in vitro and in vivo.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
- Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL. German DC, et al. J Comp Neurol. 2003 Aug 4;462(4):371-81. doi: 10.1002/cne.10737. J Comp Neurol. 2003. PMID: 12811807 - Use of YFP to study amyloid-beta associated neurite alterations in live brain slices.
Brendza RP, Simmons K, Bales KR, Paul SM, Goldberg MP, Holtzman DM. Brendza RP, et al. Neurobiol Aging. 2003 Dec;24(8):1071-7. doi: 10.1016/j.neurobiolaging.2003.04.008. Neurobiol Aging. 2003. PMID: 14643378 - Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P. Pérez M, et al. Acta Neuropathol. 2008 Oct;116(4):409-18. doi: 10.1007/s00401-008-0420-0. Epub 2008 Aug 5. Acta Neuropathol. 2008. PMID: 18679696 - Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Götz J, Ittner LM, Kins S. Götz J, et al. J Neurochem. 2006 Aug;98(4):993-1006. doi: 10.1111/j.1471-4159.2006.03955.x. Epub 2006 Jun 19. J Neurochem. 2006. PMID: 16787410 Review. - [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C, Perruchini C, Lebouvier T, Potier MC. Duyckaerts C, et al. Bull Acad Natl Med. 2008 Feb;192(2):303-18; discussion 318-21. Bull Acad Natl Med. 2008. PMID: 18819685 Review. French.
Cited by
- In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration.
Crowe SE, Ellis-Davies GC. Crowe SE, et al. J Comp Neurol. 2013 Jul 1;521(10):2181-94. doi: 10.1002/cne.23306. J Comp Neurol. 2013. PMID: 23348594 Free PMC article. - Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques.
Garcia-Marin V, Blazquez-Llorca L, Rodriguez JR, Boluda S, Muntane G, Ferrer I, Defelipe J. Garcia-Marin V, et al. Front Neuroanat. 2009 Nov 20;3:28. doi: 10.3389/neuro.05.028.2009. eCollection 2009. Front Neuroanat. 2009. PMID: 19949482 Free PMC article. - Alzheimer disease models and human neuropathology: similarities and differences.
Duyckaerts C, Potier MC, Delatour B. Duyckaerts C, et al. Acta Neuropathol. 2008 Jan;115(1):5-38. doi: 10.1007/s00401-007-0312-8. Epub 2007 Nov 16. Acta Neuropathol. 2008. PMID: 18038275 Free PMC article. Review. - Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice.
Rutten BP, Van der Kolk NM, Schafer S, van Zandvoort MA, Bayer TA, Steinbusch HW, Schmitz C. Rutten BP, et al. Am J Pathol. 2005 Jul;167(1):161-73. doi: 10.1016/S0002-9440(10)62963-X. Am J Pathol. 2005. PMID: 15972962 Free PMC article. - Combination therapy prevents amyloid-dependent and -independent structural changes.
Malthankar-Phatak G, Poplawski S, Toraskar N, Siman R. Malthankar-Phatak G, et al. Neurobiol Aging. 2012 Jul;33(7):1273-83. doi: 10.1016/j.neurobiolaging.2010.12.007. Epub 2011 Jan 22. Neurobiol Aging. 2012. PMID: 21257234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous